Privia Health price target raised to $33 from $31 at Truist

2 weeks ago 19

TipRanks

Tue, March 3, 2026 astatine 7:15 AM CST 1 min read

Truist expert Jailendra Singh raised the firm’s price target connected Privia Health (PRVA) to $33 from $31 and keeps a Buy standing connected the shares aft hosting absorption talks. The institution noted that the sequential diminution successful FFS Practice Collections was driven by a higher attraction of specialists versus superior attraction and circumstantial “retroactive” claims processing timing successful the California and North Texas markets, besides having suggested that averaging Q3 and Q4 results provides a much close practice of the underlying show for the 2nd fractional of the year, the expert tells investors successful a probe note.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected PRVA:

Disclaimer & DisclosureReport an Issue

Privia Health terms people raised to $35 from $34 astatine Canaccord
Privia Health terms people raised to $32 from $30 astatine Jefferies
Privia Health reports Q4 adjusted EPS 25c, statement 19c
Privia Health sees 2026 gross $2.35B-$2.45B, statement $2.32B
Privia Health resumed with an Outperform astatine RBC Capital

Read Entire Article